FDA approves Yulzety, a new rivaroxaban oral suspension from Rosemont PharmsOct 16Regulatory decisionrivaroxaban
Daiichi Sankyo registers Phase 3b T-DXd sequencing trial; posts RWE and access-program studiesOct 16Weekly roundup, 3 itemsAstraZenecaDaiichi Sankyo
Sign inSign in